as 07-30-2025 1:38pm EST
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Upcoming Earnings Alert:
Get ready for potential market movements as Mirion Technologies Inc. MIR prepares to release earnings report on 31 Jul 2025.
Founded: | 2005 | Country: | United States |
Employees: | N/A | City: | ATLANTA |
Market Cap: | 5.0B | IPO Year: | N/A |
Target Price: | $22.25 | AVG Volume (30 days): | 2.4M |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.05 | EPS Growth: | N/A |
52 Week Low/High: | $9.11 - $22.68 | Next Earning Date: | 07-31-2025 |
Revenue: | $870,200,000 | Revenue Growth: | 7.25% |
Revenue Growth (this year): | 6.73% | Revenue Growth (next year): | 7.58% |
MIR Breaking Stock News: Dive into MIR Ticker-Specific Updates for Smart Investing
StockStory
a month ago
Insider Monkey
a month ago
StockStory
a month ago
MT Newswires
a month ago
Business Wire
a month ago
Zacks
a month ago
Zacks
2 months ago
Business Wire
2 months ago
The information presented on this page, "MIR Mirion Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.